- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
Robert Malone, a member of the Centers for Disease Control and Prevention’s reshaped vaccine advisory committee, said Tuesday (Aug. 19) he now regrets recommending Merck’s RSV antibody for infants, clesrovimab, claiming he discovered his vote relied on “manipulated data.”
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us